APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Annotation Tools

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Annotation Tools Market Outlook and Growth Opportunities 2026

3 March 2026214 pages

Choose your research edition.

Industry ResearchMedical Annotation Tools Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Annotation Tools Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Medical Annotation Tools Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Annotation Tools Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Annotation Tools Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Medical Annotation Tools market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Annotation Tools is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Annotation Tools is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Annotation Tools is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Annotation Tools market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Annotation Tools market include Encord, MD.ai, RedBrick AI, V7 Labs, Labelbox, Cogito Tech, BasicAI, Scale AI and SuperAnnotate, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Annotation Tools market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Annotation Tools and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Annotation Tools revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Annotation Tools market.

Medical Annotation Tools Segment by Company

Encord

MD.ai

RedBrick AI

V7 Labs

Labelbox

Cogito Tech

BasicAI

Scale AI

SuperAnnotate

PathAI

Ango Hub

Appen

Supervisely

Anolytics

Alegion

Label Studio (HumanSignal)

Kili Technology

Aiforia

Proscia

Paige

Visiopharm

Indica Labs

PathPresenter

Neusoft

BasicFinder

Medical Annotation Tools Segment by Type

Medical Image

Clinical Text

Medical Video

Others

Medical Annotation Tools Segment by Application

Hospitals

Medical AI Companies

Contract Research Organizations (CROs)

Pharmaceutical Companies

Others

Medical Annotation Tools Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Annotation Tools status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Annotation Tools key companies, revenue, market share, and recent developments.

3. To split the Medical Annotation Tools breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Annotation Tools market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Annotation Tools significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Annotation Tools competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Annotation Tools market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Annotation Tools and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Annotation Tools.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Annotation Tools industry.

Chapter 3: Detailed analysis of Medical Annotation Tools company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Annotation Tools in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Annotation Tools in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Annotation Tools Industry Trends Table 2. Medical Annotation Tools Industry Drivers Table 3. Medical Annotation Tools Industry Opportunities and Challenges Table 4. Medical Annotation Tools Industry Restraints Table 5. Global Medical Annotation Tools Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Annotation Tools Revenue Share by Company (2021-2026) Table 7. Global Medical Annotation Tools Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Annotation Tools Key Company Manufacturing Base & Headquarters Table 9. Global Medical Annotation Tools Company, Product Type & Application Table 10. Global Medical Annotation Tools Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Annotation Tools by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medical Image Table 15. Significant Companies of Clinical Text Table 16. Significant Companies of Medical Video Table 17. Significant Companies of Others Table 18. Global Medical Annotation Tools Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Medical Annotation Tools Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Medical Annotation Tools Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Medical Annotation Tools Sales Value Share by Type (2021-2026) Table 22. Global Medical Annotation Tools Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Medical AI Companies Table 25. Significant Companies of Contract Research Organizations (CROs) Table 26. Significant Companies of Pharmaceutical Companies Table 27. Significant Companies of Others Table 28. Global Medical Annotation Tools Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Medical Annotation Tools Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Medical Annotation Tools Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Medical Annotation Tools Sales Value Share by Application (2021-2026) Table 32. Global Medical Annotation Tools Sales Value Share by Application (2027-2032) Table 33. Global Medical Annotation Tools Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Medical Annotation Tools Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Medical Annotation Tools Sales Value Share by Region (2021-2026) Table 36. Global Medical Annotation Tools Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Medical Annotation Tools Sales Value Share by Region (2027-2032) Table 38. Global Medical Annotation Tools Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Medical Annotation Tools Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Medical Annotation Tools Sales Value Market Share by Country (2021-2026) Table 41. Global Medical Annotation Tools Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Medical Annotation Tools Sales Value Market Share by Country (2027-2032) Table 43. Encord Company Information Table 44. Encord Business Overview Table 45. Encord Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Encord Medical Annotation Tools Product Portfolio Table 47. Encord Recent Development Table 48. MD.ai Company Information Table 49. MD.ai Business Overview Table 50. MD.ai Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. MD.ai Medical Annotation Tools Product Portfolio Table 52. MD.ai Recent Development Table 53. RedBrick AI Company Information Table 54. RedBrick AI Business Overview Table 55. RedBrick AI Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. RedBrick AI Medical Annotation Tools Product Portfolio Table 57. RedBrick AI Recent Development Table 58. V7 Labs Company Information Table 59. V7 Labs Business Overview Table 60. V7 Labs Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. V7 Labs Medical Annotation Tools Product Portfolio Table 62. V7 Labs Recent Development Table 63. Labelbox Company Information Table 64. Labelbox Business Overview Table 65. Labelbox Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Labelbox Medical Annotation Tools Product Portfolio Table 67. Labelbox Recent Development Table 68. Cogito Tech Company Information Table 69. Cogito Tech Business Overview Table 70. Cogito Tech Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cogito Tech Medical Annotation Tools Product Portfolio Table 72. Cogito Tech Recent Development Table 73. BasicAI Company Information Table 74. BasicAI Business Overview Table 75. BasicAI Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BasicAI Medical Annotation Tools Product Portfolio Table 77. BasicAI Recent Development Table 78. Scale AI Company Information Table 79. Scale AI Business Overview Table 80. Scale AI Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Scale AI Medical Annotation Tools Product Portfolio Table 82. Scale AI Recent Development Table 83. SuperAnnotate Company Information Table 84. SuperAnnotate Business Overview Table 85. SuperAnnotate Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. SuperAnnotate Medical Annotation Tools Product Portfolio Table 87. SuperAnnotate Recent Development Table 88. PathAI Company Information Table 89. PathAI Business Overview Table 90. PathAI Medical Annotation Tools Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. PathAI Medical Annotation Tools Product Portfolio Table 92. PathAI Recent Development Table 93. Ango Hub Company Information Table 94. Ango Hub Business Overview Table 95. Ango Hub Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Ango Hub Medical Annotation Tools Product Portfolio Table 97. Ango Hub Recent Development Table 98. Appen Company Information Table 99. Appen Business Overview Table 100. Appen Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Appen Medical Annotation Tools Product Portfolio Table 102. Appen Recent Development Table 103. Supervisely Company Information Table 104. Supervisely Business Overview Table 105. Supervisely Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Supervisely Medical Annotation Tools Product Portfolio Table 107. Supervisely Recent Development Table 108. Anolytics Company Information Table 109. Anolytics Business Overview Table 110. Anolytics Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Anolytics Medical Annotation Tools Product Portfolio Table 112. Anolytics Recent Development Table 113. Alegion Company Information Table 114. Alegion Business Overview Table 115. Alegion Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Alegion Medical Annotation Tools Product Portfolio Table 117. Alegion Recent Development Table 118. Label Studio (HumanSignal) Company Information Table 119. Label Studio (HumanSignal) Business Overview Table 120. Label Studio (HumanSignal) Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Label Studio (HumanSignal) Medical Annotation Tools Product Portfolio Table 122. Label Studio (HumanSignal) Recent Development Table 123. Kili Technology Company Information Table 124. Kili Technology Business Overview Table 125. Kili Technology Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Kili Technology Medical Annotation Tools Product Portfolio Table 127. Kili Technology Recent Development Table 128. Aiforia Company Information Table 129. Aiforia Business Overview Table 130. Aiforia Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Aiforia Medical Annotation Tools Product Portfolio Table 132. Aiforia Recent Development Table 133. Proscia Company Information Table 134. Proscia Business Overview Table 135. Proscia Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Proscia Medical Annotation Tools Product Portfolio Table 137. Proscia Recent Development Table 138. Paige Company Information Table 139. Paige Business Overview Table 140. Paige Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Paige Medical Annotation Tools Product Portfolio Table 142. Paige Recent Development Table 143. Visiopharm Company Information Table 144. Visiopharm Business Overview Table 145. Visiopharm Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Visiopharm Medical Annotation Tools Product Portfolio Table 147. Visiopharm Recent Development Table 148. Indica Labs Company Information Table 149. Indica Labs Business Overview Table 150. Indica Labs Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Indica Labs Medical Annotation Tools Product Portfolio Table 152. Indica Labs Recent Development Table 153. PathPresenter Company Information Table 154. PathPresenter Business Overview Table 155. PathPresenter Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. PathPresenter Medical Annotation Tools Product Portfolio Table 157. PathPresenter Recent Development Table 158. Neusoft Company Information Table 159. Neusoft Business Overview Table 160. Neusoft Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Neusoft Medical Annotation Tools Product Portfolio Table 162. Neusoft Recent Development Table 163. BasicFinder Company Information Table 164. BasicFinder Business Overview Table 165. BasicFinder Medical Annotation Tools Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. BasicFinder Medical Annotation Tools Product Portfolio Table 167. BasicFinder Recent Development Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Medical Annotation Tools Product Image Figure 2. Global Medical Annotation Tools Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Annotation Tools Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Annotation Tools Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medical Image Image Figure 8. Clinical Text Image Figure 9. Medical Video Image Figure 10. Others Image Figure 11. Global Medical Annotation Tools Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Medical Annotation Tools Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Medical Annotation Tools Sales Value Share by Type (2021-2032) Figure 14. Hospitals Image Figure 15. Medical AI Companies Image Figure 16. Contract Research Organizations (CROs) Image Figure 17. Pharmaceutical Companies Image Figure 18. Others Image Figure 19. Global Medical Annotation Tools Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Medical Annotation Tools Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Medical Annotation Tools Sales Value Share by Application (2021-2032) Figure 22. Global Medical Annotation Tools Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Medical Annotation Tools Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Medical Annotation Tools Sales Value (2021-2032) & (US$ Million) Figure 25. North America Medical Annotation Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Medical Annotation Tools Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Medical Annotation Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Medical Annotation Tools Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Medical Annotation Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Medical Annotation Tools Sales Value (2021-2032) & (US$ Million) Figure 31. South America Medical Annotation Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Medical Annotation Tools Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Medical Annotation Tools Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Medical Annotation Tools Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Image
  • Clinical Text
  • Medical Video
  • Others
Applications
  • Hospitals
  • Medical AI Companies
  • Contract Research Organizations (CROs)
  • Pharmaceutical Companies
  • Others
Companies covered
  • Encord
  • MD.ai
  • RedBrick AI
  • V7 Labs
  • Labelbox
  • Cogito Tech
  • BasicAI
  • Scale AI
  • SuperAnnotate
  • PathAI
  • Ango Hub
  • Appen
  • Supervisely
  • Anolytics
  • Alegion
  • Label Studio (HumanSignal)
  • Kili Technology
  • Aiforia
  • Proscia
  • Paige
  • Visiopharm
  • Indica Labs
  • PathPresenter
  • Neusoft
  • BasicFinder

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Annotation Tools Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Annotation Tools Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Annotation Tools Market Dynamics
  1. 2.1 Medical Annotation Tools Industry Trends
  2. 2.2 Medical Annotation Tools Industry Drivers
  3. 2.3 Medical Annotation Tools Industry Opportunities and Challenges
  4. 2.4 Medical Annotation Tools Industry Restraints
3 Medical Annotation Tools Market by Company
  1. 3.1 Global Medical Annotation Tools Company Revenue Ranking in 2025
  2. 3.2 Global Medical Annotation Tools Revenue by Company (2021-2026)
  3. 3.3 Global Medical Annotation Tools Company Ranking (2024-2026)
  4. 3.4 Global Medical Annotation Tools Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Annotation Tools Company Product Type and Application
  6. 3.6 Global Medical Annotation Tools Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Annotation Tools Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Annotation Tools Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Annotation Tools Market by Type
  1. 4.1 Medical Annotation Tools Type Introduction
  2. 4.1.1 Medical Image
  3. 4.1.2 Clinical Text
  4. 4.1.3 Medical Video
  5. 4.1.4 Others
  6. 4.2 Global Medical Annotation Tools Sales Value by Type
  7. 4.2.1 Global Medical Annotation Tools Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medical Annotation Tools Sales Value by Type (2021-2032)
  9. 4.2.3 Global Medical Annotation Tools Sales Value Share by Type (2021-2032)
5 Medical Annotation Tools Market by Application
  1. 5.1 Medical Annotation Tools Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Medical AI Companies
  4. 5.1.3 Contract Research Organizations (CROs)
  5. 5.1.4 Pharmaceutical Companies
  6. 5.1.5 Others
  7. 5.2 Global Medical Annotation Tools Sales Value by Application
  8. 5.2.1 Global Medical Annotation Tools Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Medical Annotation Tools Sales Value by Application (2021-2032)
  10. 5.2.3 Global Medical Annotation Tools Sales Value Share by Application (2021-2032)
6 Medical Annotation Tools Regional Value Analysis
  1. 6.1 Global Medical Annotation Tools Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Annotation Tools Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Annotation Tools Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Annotation Tools Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Annotation Tools Sales Value (2021-2032)
  7. 6.3.2 North America Medical Annotation Tools Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Annotation Tools Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Annotation Tools Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Annotation Tools Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Annotation Tools Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Annotation Tools Sales Value (2021-2032)
  16. 6.6.2 South America Medical Annotation Tools Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Annotation Tools Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Annotation Tools Sales Value Share by Country, 2025 VS 2032
7 Medical Annotation Tools Country-level Value Analysis
  1. 7.1 Global Medical Annotation Tools Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Annotation Tools Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Annotation Tools Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Annotation Tools Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Annotation Tools Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Annotation Tools Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Annotation Tools Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Encord
  2. 8.1.1 Encord Company Information
  3. 8.1.2 Encord Business Overview
  4. 8.1.3 Encord Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Encord Medical Annotation Tools Product Portfolio
  6. 8.1.5 Encord Recent Developments
  7. 8.2 MD.ai
  8. 8.2.1 MD.ai Company Information
  9. 8.2.2 MD.ai Business Overview
  10. 8.2.3 MD.ai Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MD.ai Medical Annotation Tools Product Portfolio
  12. 8.2.5 MD.ai Recent Developments
  13. 8.3 RedBrick AI
  14. 8.3.1 RedBrick AI Company Information
  15. 8.3.2 RedBrick AI Business Overview
  16. 8.3.3 RedBrick AI Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RedBrick AI Medical Annotation Tools Product Portfolio
  18. 8.3.5 RedBrick AI Recent Developments
  19. 8.4 V7 Labs
  20. 8.4.1 V7 Labs Company Information
  21. 8.4.2 V7 Labs Business Overview
  22. 8.4.3 V7 Labs Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  23. 8.4.4 V7 Labs Medical Annotation Tools Product Portfolio
  24. 8.4.5 V7 Labs Recent Developments
  25. 8.5 Labelbox
  26. 8.5.1 Labelbox Company Information
  27. 8.5.2 Labelbox Business Overview
  28. 8.5.3 Labelbox Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Labelbox Medical Annotation Tools Product Portfolio
  30. 8.5.5 Labelbox Recent Developments
  31. 8.6 Cogito Tech
  32. 8.6.1 Cogito Tech Company Information
  33. 8.6.2 Cogito Tech Business Overview
  34. 8.6.3 Cogito Tech Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cogito Tech Medical Annotation Tools Product Portfolio
  36. 8.6.5 Cogito Tech Recent Developments
  37. 8.7 BasicAI
  38. 8.7.1 BasicAI Company Information
  39. 8.7.2 BasicAI Business Overview
  40. 8.7.3 BasicAI Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BasicAI Medical Annotation Tools Product Portfolio
  42. 8.7.5 BasicAI Recent Developments
  43. 8.8 Scale AI
  44. 8.8.1 Scale AI Company Information
  45. 8.8.2 Scale AI Business Overview
  46. 8.8.3 Scale AI Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Scale AI Medical Annotation Tools Product Portfolio
  48. 8.8.5 Scale AI Recent Developments
  49. 8.9 SuperAnnotate
  50. 8.9.1 SuperAnnotate Company Information
  51. 8.9.2 SuperAnnotate Business Overview
  52. 8.9.3 SuperAnnotate Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SuperAnnotate Medical Annotation Tools Product Portfolio
  54. 8.9.5 SuperAnnotate Recent Developments
  55. 8.10 PathAI
  56. 8.10.1 PathAI Company Information
  57. 8.10.2 PathAI Business Overview
  58. 8.10.3 PathAI Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PathAI Medical Annotation Tools Product Portfolio
  60. 8.10.5 PathAI Recent Developments
  61. 8.11 Ango Hub
  62. 8.11.1 Ango Hub Company Information
  63. 8.11.2 Ango Hub Business Overview
  64. 8.11.3 Ango Hub Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ango Hub Medical Annotation Tools Product Portfolio
  66. 8.11.5 Ango Hub Recent Developments
  67. 8.12 Appen
  68. 8.12.1 Appen Company Information
  69. 8.12.2 Appen Business Overview
  70. 8.12.3 Appen Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Appen Medical Annotation Tools Product Portfolio
  72. 8.12.5 Appen Recent Developments
  73. 8.13 Supervisely
  74. 8.13.1 Supervisely Company Information
  75. 8.13.2 Supervisely Business Overview
  76. 8.13.3 Supervisely Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Supervisely Medical Annotation Tools Product Portfolio
  78. 8.13.5 Supervisely Recent Developments
  79. 8.14 Anolytics
  80. 8.14.1 Anolytics Company Information
  81. 8.14.2 Anolytics Business Overview
  82. 8.14.3 Anolytics Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Anolytics Medical Annotation Tools Product Portfolio
  84. 8.14.5 Anolytics Recent Developments
  85. 8.15 Alegion
  86. 8.15.1 Alegion Company Information
  87. 8.15.2 Alegion Business Overview
  88. 8.15.3 Alegion Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alegion Medical Annotation Tools Product Portfolio
  90. 8.15.5 Alegion Recent Developments
  91. 8.16 Label Studio (HumanSignal)
  92. 8.16.1 Label Studio (HumanSignal) Company Information
  93. 8.16.2 Label Studio (HumanSignal) Business Overview
  94. 8.16.3 Label Studio (HumanSignal) Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Label Studio (HumanSignal) Medical Annotation Tools Product Portfolio
  96. 8.16.5 Label Studio (HumanSignal) Recent Developments
  97. 8.17 Kili Technology
  98. 8.17.1 Kili Technology Company Information
  99. 8.17.2 Kili Technology Business Overview
  100. 8.17.3 Kili Technology Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Kili Technology Medical Annotation Tools Product Portfolio
  102. 8.17.5 Kili Technology Recent Developments
  103. 8.18 Aiforia
  104. 8.18.1 Aiforia Company Information
  105. 8.18.2 Aiforia Business Overview
  106. 8.18.3 Aiforia Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aiforia Medical Annotation Tools Product Portfolio
  108. 8.18.5 Aiforia Recent Developments
  109. 8.19 Proscia
  110. 8.19.1 Proscia Company Information
  111. 8.19.2 Proscia Business Overview
  112. 8.19.3 Proscia Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Proscia Medical Annotation Tools Product Portfolio
  114. 8.19.5 Proscia Recent Developments
  115. 8.20 Paige
  116. 8.20.1 Paige Company Information
  117. 8.20.2 Paige Business Overview
  118. 8.20.3 Paige Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Paige Medical Annotation Tools Product Portfolio
  120. 8.20.5 Paige Recent Developments
  121. 8.21 Visiopharm
  122. 8.21.1 Visiopharm Company Information
  123. 8.21.2 Visiopharm Business Overview
  124. 8.21.3 Visiopharm Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Visiopharm Medical Annotation Tools Product Portfolio
  126. 8.21.5 Visiopharm Recent Developments
  127. 8.22 Indica Labs
  128. 8.22.1 Indica Labs Company Information
  129. 8.22.2 Indica Labs Business Overview
  130. 8.22.3 Indica Labs Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Indica Labs Medical Annotation Tools Product Portfolio
  132. 8.22.5 Indica Labs Recent Developments
  133. 8.23 PathPresenter
  134. 8.23.1 PathPresenter Company Information
  135. 8.23.2 PathPresenter Business Overview
  136. 8.23.3 PathPresenter Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  137. 8.23.4 PathPresenter Medical Annotation Tools Product Portfolio
  138. 8.23.5 PathPresenter Recent Developments
  139. 8.24 Neusoft
  140. 8.24.1 Neusoft Company Information
  141. 8.24.2 Neusoft Business Overview
  142. 8.24.3 Neusoft Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Neusoft Medical Annotation Tools Product Portfolio
  144. 8.24.5 Neusoft Recent Developments
  145. 8.25 BasicFinder
  146. 8.25.1 BasicFinder Company Information
  147. 8.25.2 BasicFinder Business Overview
  148. 8.25.3 BasicFinder Medical Annotation Tools Revenue and Gross Margin (2021-2026)
  149. 8.25.4 BasicFinder Medical Annotation Tools Product Portfolio
  150. 8.25.5 BasicFinder Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst